Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's disease (AD) is a severe neurological illness that demolishes memory and brain functioning. This disease affects an individual's capacity to work, think, and behave. The proportion of individuals suffering from AD is rapidly increasing. It flatters a leading cause of disability and impacts millions of people worldwide. Early detection reduces disease expansion, provides more effective ...
The immersive experience provided by our approach empowers researchers with an intuitive exploration of brain structures. Within the brain's central nervous system, encompassing both white and gray matter, symptoms associated with Alzheimer's disease (AD) often manifest through gray matter decline. The manual identification of these changes proves to be a time-intensive endeavor. Although learning...
BACKGROUND: Dementia is a neurological syndrome marked by cognitive decline. Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the common...
Recent advancements in the classification of Alzheimer's disease have leveraged the automatic feature generation capability of convolutional neural ne...
The Morris Water Maze (MWM) is a widely used behavioral test to assess the spatial learning and memory of animals, particularly valuable in studying n...
PURPOSE: This study explores the application of machine learning to high-dimensional proteomics datasets for identifying Alzheimer's disease (AD) biom...
Within precision psychiatry, there is a growing interest in normative models given their ability to parse heterogeneity. While they are intuitive and ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease marked by motor deterioration and cognitive decline. Early diagnosis is challengin...
Complex diseases pose challenges in prediction due to their multifactorial and polygenic nature. This study employed machine learning (ML) to analyze ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by a gradual decline in cognitive function. Currently, there are no...
BACKGROUND: The atherosclerotic cardiovascular disease (ASCVD) is associated with dementia. However, the risk factors of dementia in patients with ASC...
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder that significantly impacts health care worldwide, particularly among the elderly ...
Both brain functional connectivity (FC) and structural connectivity (SC) provide distinct neural mechanisms for cognition and neurological disease. In...
BackgroundMost common forms of dementia, including Alzheimer's disease, are associated with alterations in spoken language.ObjectiveThis study explore...
BACKGROUND: Understanding the dementia disease trajectory and clinical practice patterns in outpatient settings is vital for effective management. Kno...
Current pharmacotherapy for neurodegenerative diseases is limited to providing symptomatic relief, instead of slowing or reversing disease progression...
Brain age (BA), distinct from chronological age (CA), can be estimated from MRIs to evaluate neuroanatomic aging in cognitively normal (CN) individual...
Dementia rates are projected to increase significantly by 2050, posing considerable challenges for healthcare systems worldwide. Developing efficient ...
Alzheimer's disease (AD) is the most common cause of dementia, emphasizing the critical need for the development of biomarkers that facilitate accurat...
The integration of diverse clinical modalities such as medical imaging and the tabular data extracted from patients' Electronic Health Records (EHRs) ...